From: Mapping the output of the global literature on the links between gut microbiota and COVID-19
Authors | Title | Year | Source title | Cited by |
---|---|---|---|---|
Zuo et al. [25] | “Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization” | 2020 | Gastroenterology | 580 |
Yeoh et al. [22] | “Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19” | 2021 | Gut | 334 |
Dhar and Mohanty [17] | “Gut microbiota and Covid-19—possible link and implications” | 2020 | Virus Research | 313 |
Gu et al. [18] | “Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza” | 2020 | Clinical Infectious Diseases | 296 |
Zuo et al. [23] | “Depicting SARS-CoV-2 fecal viral activity in association with gut microbiota composition in patients with COVID-19” | 2021 | Gut | 196 |
Zuo et al. [24] | “Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge” | 2020 | Gastroenterology | 137 |
Saleh et al. [20] | “Mitochondria and microbiota dysfunction in COVID-19 pathogenesis” | 2020 | Mitochondrion | 134 |
Villapol [21] | “Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome” | 2020 | Translational Research | 133 |
Baud et al. [16] | “Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic” | 2020 | Frontiers in Public Health | 114 |
Infusino et al. [19] | Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: A scoping review | 2020 | Nutrients | 107 |
Mak et al. [67] | “Probiotics and COVID-19: one size does not fit all” | 2020 | The Lancet Gastroenterology and Hepatology | 102 |